Type III Secretion System in Intestinal Pathogens and Metabolic Diseases
Modern lifestyle changes, especially the consumption of a diet high in salt, sugar, and fat, have contributed to the increasing incidence and prevalence of chronic metabolic diseases such as diabetes, obesity, and gout. Changing lifestyles continuously shape the gut microbiota which is closely relat...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2024/4864639 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832546445766426624 |
|---|---|
| author | Le Zhou Yaoyuan Zhang Shiqi Wu Yiyu Kuang Pengfei Jiang Xiao Zhu Kai Yin |
| author_facet | Le Zhou Yaoyuan Zhang Shiqi Wu Yiyu Kuang Pengfei Jiang Xiao Zhu Kai Yin |
| author_sort | Le Zhou |
| collection | DOAJ |
| description | Modern lifestyle changes, especially the consumption of a diet high in salt, sugar, and fat, have contributed to the increasing incidence and prevalence of chronic metabolic diseases such as diabetes, obesity, and gout. Changing lifestyles continuously shape the gut microbiota which is closely related to the occurrence and development of metabolic diseases due to its specificity of composition and structural diversity. A large number of pathogenic bacteria such as Yersinia, Salmonella, Shigella, and pathogenic E. coli in the gut utilize the type III secretion system (T3SS) to help them resist host defenses and cause disease. Although the T3SS is critical for the virulence of many important human pathogens, its relationship with metabolic diseases remains unknown. This article reviews the structure and function of the T3SS, the disruption of intestinal barrier integrity by the T3SS, the changes in intestinal flora containing the T3SS in metabolic diseases, the possible mechanisms of the T3SS affecting metabolic diseases, and the application of the T3SS in the treatment of metabolic diseases. The aim is to provide insights into metabolic diseases targeting the T3SS, thereby serving as a valuable reference for future research on disease diagnosis, prevention, and treatment. |
| format | Article |
| id | doaj-art-1f3a9abd82cc41bcb3abc9fd396a10fa |
| institution | Kabale University |
| issn | 2314-6753 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Diabetes Research |
| spelling | doaj-art-1f3a9abd82cc41bcb3abc9fd396a10fa2025-02-03T06:49:25ZengWileyJournal of Diabetes Research2314-67532024-01-01202410.1155/2024/4864639Type III Secretion System in Intestinal Pathogens and Metabolic DiseasesLe Zhou0Yaoyuan Zhang1Shiqi Wu2Yiyu Kuang3Pengfei Jiang4Xiao Zhu5Kai Yin6Guangxi Key Laboratory of Diabetic Systems MedicineDepartment of General PracticeGuangxi Key Laboratory of Diabetic Systems MedicineGuangxi Key Laboratory of Diabetic Systems MedicineGuangxi Key Laboratory of Diabetic Systems MedicineGuangxi Key Laboratory of Diabetic Systems MedicineDepartment of General PracticeModern lifestyle changes, especially the consumption of a diet high in salt, sugar, and fat, have contributed to the increasing incidence and prevalence of chronic metabolic diseases such as diabetes, obesity, and gout. Changing lifestyles continuously shape the gut microbiota which is closely related to the occurrence and development of metabolic diseases due to its specificity of composition and structural diversity. A large number of pathogenic bacteria such as Yersinia, Salmonella, Shigella, and pathogenic E. coli in the gut utilize the type III secretion system (T3SS) to help them resist host defenses and cause disease. Although the T3SS is critical for the virulence of many important human pathogens, its relationship with metabolic diseases remains unknown. This article reviews the structure and function of the T3SS, the disruption of intestinal barrier integrity by the T3SS, the changes in intestinal flora containing the T3SS in metabolic diseases, the possible mechanisms of the T3SS affecting metabolic diseases, and the application of the T3SS in the treatment of metabolic diseases. The aim is to provide insights into metabolic diseases targeting the T3SS, thereby serving as a valuable reference for future research on disease diagnosis, prevention, and treatment.http://dx.doi.org/10.1155/2024/4864639 |
| spellingShingle | Le Zhou Yaoyuan Zhang Shiqi Wu Yiyu Kuang Pengfei Jiang Xiao Zhu Kai Yin Type III Secretion System in Intestinal Pathogens and Metabolic Diseases Journal of Diabetes Research |
| title | Type III Secretion System in Intestinal Pathogens and Metabolic Diseases |
| title_full | Type III Secretion System in Intestinal Pathogens and Metabolic Diseases |
| title_fullStr | Type III Secretion System in Intestinal Pathogens and Metabolic Diseases |
| title_full_unstemmed | Type III Secretion System in Intestinal Pathogens and Metabolic Diseases |
| title_short | Type III Secretion System in Intestinal Pathogens and Metabolic Diseases |
| title_sort | type iii secretion system in intestinal pathogens and metabolic diseases |
| url | http://dx.doi.org/10.1155/2024/4864639 |
| work_keys_str_mv | AT lezhou typeiiisecretionsysteminintestinalpathogensandmetabolicdiseases AT yaoyuanzhang typeiiisecretionsysteminintestinalpathogensandmetabolicdiseases AT shiqiwu typeiiisecretionsysteminintestinalpathogensandmetabolicdiseases AT yiyukuang typeiiisecretionsysteminintestinalpathogensandmetabolicdiseases AT pengfeijiang typeiiisecretionsysteminintestinalpathogensandmetabolicdiseases AT xiaozhu typeiiisecretionsysteminintestinalpathogensandmetabolicdiseases AT kaiyin typeiiisecretionsysteminintestinalpathogensandmetabolicdiseases |